The novel intravesical drug delivery system releases erdafitinib locally within the bladder while limiting systemic ...

Quoc-Dien Trinh, MD, MBA, chief of urology at Brigham & Women's Faulkner Hospital, highlighted successful efforts to improve ...

Patients with small or slow-growing tumors or those with comorbidities that make them higher risk are likely better ...

Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center, discusses how to accurately ...

Evolving treatment for bladder cancer is going to require a multidisciplinary team to ensure patients are receiving optimal care, said Neal D. Shore, MD, FACS, medical director of the Carolina ...

Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and ...

Lower rates of cardiac surgery were found in patients living with HIV along with an increased risk of adverse events.

A retrospective analysis suggested that immune cells play a role in the progression of paroxysmal nocturnal hemoglobinuria ...

Authors primarily from the West German Cancer Center in Essen, Germany, presented findings from a phase 2 study (NCT04205552) ...

There was a marked increase in the prevalence of targeted therapy among patients with chronic lymphocytic leukemia (CLL), ...

A predictive model using plasma proteins as biomarkers predicted hepatocellular carcinoma development more accurately than a ...

A new definition of rectal cancer in the Netherlands prompted reclassification of cancer as sigmoid tumors, which could lead ...